Table 1.
Sample characteristics and incontinence pad prescription among prostate cancer patients underwent radical prostatectomy between 2012–2015 in Austria and cancer-free control men.
| Prostate Cancer Patients Underwent RP 1 | Cancer Free Controls | ||||
|---|---|---|---|---|---|
| Open | Minimally Invasive | Total | With Non-Operated BPH 2 | Without BPH | |
| Number of Cases (n) | 3262 | 2986 | 6248 | 7158 | 50,257 |
| 2013 | 1227 | 932 | 2159 | ||
| 2014 | 1055 | 1008 | 2063 | ||
| 2015 | 980 | 1046 | 2026 | ||
| Age (years), median (Q1–Q3) |
64.6 (58.8–68.7) | 64.6 (58.8–69.6) | 64.6 (58.8–69.1) | 70.8 (62.5–77.9) | 64.3 (54.3–74.4) |
| Patients received incontinence pad prescription (n) | 54 | 504 | |||
| Preoperative | 15 | 36 | 51 | ||
| Postoperative | 175 | 737 | 912 | ||
| Total number of incontinence pad prescription (n) | |||||
| Postoperative | 13,280 | 4971 | 18,251 | ||
| Total number of prescribed incontinence pad (n) | 42,813 | 591,390 | |||
| Preoperative (from 1/1/2011) | 1613 | 6947 | 8560 | ||
| Postoperative | 135,106 | 809,899 | 945,005 | ||
| Monthly rate of prescribed incontinence pads [95% CI] | 0.06 (0.04–0.09) | 0.12 (0.10–0.14) | |||
| Preoperative | 0.01 (0.01–0.02) | 0.05 (0.03–0.08) | 0.03 (0.02–0.05) | ||
| 3 months postoperative | 3.61 (2.58–3.78) | 22.94 (20.97–24.97) | 12.61 (11.59–13.65) | ||
| 12 months postoperative | 1.70 (1.32–2.11) | 12.19 (11.01–13.42) | 6.71 (6.10–7.34) | ||
| 36 months postoperative | 1.15 (0.84–1.50) | 7.51 (6.69–8.35) | 4.91 (3.76–4.62) | ||
1 Radical prostatectomy; 2 benign prostatic hyperplasia.